Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated
- PMID: 20479711
- PMCID: PMC3049187
- DOI: 10.1038/bmt.2010.112
Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated
Abstract
Blood stream infection (BSI) and acute GVHD (aGVHD) are serious complications of hematopoietic SCT (HSCT). We hypothesized that the two events were not independent of one another. We studied (1) associations between BSI and aGVHD; and (2) the impact of BSI and/or aGVHD on death within 100 days after HSCT, using a retrospective cohort analysis. Risk factor analysis was carried out using multivariable Cox proportional hazards analyses. Of 211 patients who underwent allogeneic HSCT from January 2000 to December 2005 (58% of whom underwent reduced intensity transplantation), 82 (39%) developed BSI. In 49 patients (23%), grade (gr) 2-4 aGVHD occurred. Early BSI was independently associated with an increased occurrence of subsequent aGVHD gr 2-4. CMV seropositivity was independently associated with decreased occurrence of aGVHD. aGVHD gr 2-4 independently predicted subsequent first BSI. Both BSI and aGVHD gr 2-4 were significant independent predictors of death within 100 days after HSCT. There is a strong, independent association between BSI and aGVHD. Potential explanations include the elaboration of cytokines during BSI favoring the development of aGVHD and/or the immunosuppressive treatment of aGVHD favoring the development of BSI. Future studies should be directed at the mechanistic investigations of this association.
Conflict of interest statement
CONFLICTS OF INTEREST
There were no conflicts of interest for any authors.
Figures
Similar articles
-
Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.Transpl Infect Dis. 2020 Feb;22(1):e13217. doi: 10.1111/tid.13217. Epub 2019 Dec 9. Transpl Infect Dis. 2020. PMID: 31769584
-
Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study.Bone Marrow Transplant. 2021 Sep;56(9):2125-2136. doi: 10.1038/s41409-021-01291-0. Epub 2021 Apr 19. Bone Marrow Transplant. 2021. PMID: 33875815
-
Early blood stream infection following allogeneic hematopoietic stem cell transplantation is a risk factor for acute grade III-IV GVHD in children and adolescents.Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26821. Epub 2017 Sep 17. Pediatr Blood Cancer. 2018. PMID: 28921804
-
Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients.Transplant Cell Ther. 2021 Feb;27(2):176.e1-176.e8. doi: 10.1016/j.jtct.2020.10.009. Epub 2020 Dec 11. Transplant Cell Ther. 2021. PMID: 33830032
-
Allogenic stem cell transplant-associated acute graft versus host disease: a computational drug discovery text mining approach using oral and gut microbiome signatures.Support Care Cancer. 2021 Apr;29(4):1765-1779. doi: 10.1007/s00520-020-05821-2. Epub 2020 Oct 22. Support Care Cancer. 2021. PMID: 33094358 Review.
Cited by
-
G-CSF-primed haplo-identical HSCT with intensive immunosuppressive and myelosuppressive treatments does not increase the risk of pre-engraftment bloodstream infection: a multicenter case-control study.Eur J Clin Microbiol Infect Dis. 2019 May;38(5):865-876. doi: 10.1007/s10096-019-03482-6. Epub 2019 Jan 26. Eur J Clin Microbiol Infect Dis. 2019. PMID: 30685808 Clinical Trial.
-
Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients.Bone Marrow Transplant. 2014 Jun;49(6):824-30. doi: 10.1038/bmt.2014.37. Epub 2014 Mar 24. Bone Marrow Transplant. 2014. PMID: 24662420
-
Bacterial sepsis and GI tract GVHD: more commensal than you think.Blood. 2012 Jul 5;120(1):6-7. doi: 10.1182/blood-2012-05-427435. Blood. 2012. PMID: 22767576 Free PMC article.
-
Clinical Characteristics, Microbiology, and Risk Factors for Mortality of Pre-Engraftment and Post-Engraftment Bloodstream Infection in Hematopoietic Stem Cell Transplantation Recipients.Infect Drug Resist. 2022 Nov 28;15:6893-6905. doi: 10.2147/IDR.S392804. eCollection 2022. Infect Drug Resist. 2022. PMID: 36465805 Free PMC article.
-
Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors.EJHaem. 2024 Feb 5;5(1):117-124. doi: 10.1002/jha2.842. eCollection 2024 Feb. EJHaem. 2024. PMID: 38406518 Free PMC article.
References
-
- Poutsiaka DD, Price LL, Ucuzian A, Chan GW, Miller KB, Snydman DR. Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality. Bone Marrow Transplant. 2007;40(1):63–70. - PubMed
-
- Copelan EA. Hematopoietic stem-cell transplantation [see comment] New Engl J Med. 2006;354(17):1813–26. - PubMed
-
- Duran-Struuck R, Reddy P. Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplantation. 2008;85(3):303–8. - PubMed
-
- Miller KB, Roberts TF, Chan G, Schenkein DP, Lawrence D, Sprague K, et al. A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease. Bone Marrow Transplant. 2004;33(9):881–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources